Isabelle Fusier

AP HP, 7, Rue Du Fer À-Moulin
Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Hybrid medicines in France. Hybrid medicines: Overviews in France and in Paris Public Hospitals

Hybrid medicines in France. Hybrid medicines: Overviews in France and in Paris Public Hospitals

Journal: Annales pharmaceutiques francaises

Published: November 15, 2020

Hybrid medicines in France. Hybrid medicines: Genesis and legal framework in Europe and in France

Hybrid medicines in France. Hybrid medicines: Genesis and legal framework in Europe and in France

Journal: Annales pharmaceutiques francaises

Published: November 15, 2020

Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France.

Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France.

Journal: Journal of comparative effectiveness research

Published: March 15, 2018

Hepatitis C: how has France limited the expenses related to new treatments?

Hepatitis C: how has France limited the expenses related to new treatments?

Journal: Expert review of pharmacoeconomics & outcomes research

Published: October 13, 2016

Defibrotide in Severe Sinusoidal Obstruction Syndrome: Medicine and Economic Issues.

Defibrotide in Severe Sinusoidal Obstruction Syndrome: Medicine and Economic Issues.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: September 08, 2016

Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience.

Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience.

Journal: PharmacoEconomics

Published: July 15, 2016

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

Journal: Medecine et maladies infectieuses

Published: June 22, 2015

Economic Burden of Intravenous Iron Products In Public Hospitals of Paris and Impact of Their New Hospital-Restricted Status.

Economic Burden of Intravenous Iron Products In Public Hospitals of Paris and Impact of Their New Hospital-Restricted Status.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 01, 2014

Biosimilar versus patented erythropoietins: learning from 5 years of European and Japanese experience.

Biosimilar versus patented erythropoietins: learning from 5 years of European and Japanese experience.

Journal: Applied health economics and health policy

Published: September 06, 2014

Biosimilar granulocyte colony-stimulating factor uptakes in the EU-5 markets: a descriptive analysis.

Biosimilar granulocyte colony-stimulating factor uptakes in the EU-5 markets: a descriptive analysis.

Journal: Applied health economics and health policy

Published: March 01, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026